Efficacy and safety of Cortexin as additional therapy in patients with depressive disorder
The use of Cortexin as an additional therapy in patients with depressive disorder is effective and safe. Combined antidepressant therapy with Cortexin is superior to antidepressant monotherapy in terms of response rate and health-related quality of life. A more favorable safety profile was also demonstrated for the combination of antidepressants and Cortexin.
Authors
- ED Schastnyy
Institutions
- Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (RU)
- Tomsk National Research Medical Center (RU)
Publication Details
- Journal
- S S Korsakov Journal of Neurology and Psychiatry
- Published
- 2026-03-05
- DOI
- https://doi.org/10.17116/jnevro202612602192
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00